Remove Data Remove DEA Remove Safety
article thumbnail

Federal vs. State Approaches to Cannabis: Recent DEA Data Shows Increase In Enforcement While States Move Toward Decriminalization and Legalization

The Blunt Truth

According to recent data from the Drug Enforcement Administration , however, in 2021, federal law enforcement agents seized over 5.5 One might think that the recent uptick in the legalization of recreational marijuana usage would correlate with a decline in the arrests and seizures related to the leafy-green.

DEA 98
article thumbnail

Federal vs. State Approaches to Cannabis: Recent DEA Data Shows Increase In Enforcement While States Move Toward Decriminalization and Legalization

Cannabis Law Report

According to recent data from the Drug Enforcement Administration , however, in 2021, federal law enforcement agents seized over 5.5 One might think that the recent uptick in the legalization of recreational marijuana usage would correlate with a decline in the arrests and seizures related to the leafy-green.

DEA 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Federal vs. State Approaches to Cannabis: Recent DEA Data Shows Increase In Enforcement While States Move Toward Decriminalization and Legalization

Cannabis Law Report

According to recent data from the Drug Enforcement Administration , however, in 2021, federal law enforcement agents seized over 5.5 One might think that the recent uptick in the legalization of recreational marijuana usage would correlate with a decline in the arrests and seizures related to the leafy-green.

DEA 52
article thumbnail

DEA Approves MMJ International Holdings THC Shipment for Multiple Sclerosis, Huntington’s Disease Drug Development

Cannabis Law Report

MMJ International Holdings, the premier medical cannabis research company, announced that it has received DEA approval to ship THC and CBD from Canada. ”We are pleased with the DEA ‘s cooperation and support to facilitate our company mission to service the unmet needs of patients suffering from these chronic diseases.”

DEA 66
article thumbnail

The Epidiolex Effect: Will Other CBD Drugs Receive FDA and DEA Approval?

Freedom Leaf

On September 28, the DEA designated Epidiolex —a plant-based CBD pharmaceutical manufactured by the UK-based GW Pharmaceuticals—a Schedule V drug in the government’s list of controlled substances. Frontier Data predicts total sales of all CBD products in the U.S. Frontier Data predicts total sales of all CBD products in the U.S.

DEA 51
article thumbnail

Delta-8 Study Finds Products Used More In States Without Legal Cannabis

Veriheal

Since delta-8 is so unpopular in states with legal cannabis, the data suggests that it is often less appealing to consumers than actual weed. The Drug Enforcement Administration (DEA) is working on amending the Farm Bill in 2024 to create new rules and regulations regarding synthetic weed.

article thumbnail

Psilocybin-Alcohol Study, FDA’s Psychedelic Guide, & the NCAA’s Cannabis Overhaul Begins

Veriheal

The 14-page document covers several aspects of the drug development process, including trial best practices, data collection, and new drug application requirements. The document also addresses study participant safety emphasizing how psychedelics’ psychoactive effects increase the potential for abuse.